CN118830816A - Microvascular endothelial function detection method, device, electronic equipment and storage medium - Google Patents
Microvascular endothelial function detection method, device, electronic equipment and storage medium Download PDFInfo
- Publication number
- CN118830816A CN118830816A CN202411290938.1A CN202411290938A CN118830816A CN 118830816 A CN118830816 A CN 118830816A CN 202411290938 A CN202411290938 A CN 202411290938A CN 118830816 A CN118830816 A CN 118830816A
- Authority
- CN
- China
- Prior art keywords
- oxygen saturation
- index
- blood oxygen
- blood
- target user
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F18/00—Pattern recognition
- G06F18/20—Analysing
- G06F18/27—Regression, e.g. linear or logistic regression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Data Mining & Analysis (AREA)
- Physiology (AREA)
- Theoretical Computer Science (AREA)
- Cardiology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Artificial Intelligence (AREA)
- Evolutionary Computation (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Vascular Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本公开提供了一种微血管内皮功能检测方法、装置、电子设备及存储介质,方法包括:获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值;根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数;当所述血管内皮功能异常指数大于异常指数阈值时,确定所述目标用户存在血管内皮功能障碍。
The present disclosure provides a microvascular endothelial function detection method, device, electronic device and storage medium, the method comprising: obtaining a target user's basic blood oxygen saturation, a blood oxygen saturation net recovery time and a blood perfusion index increase; determining a vascular endothelial function abnormality index according to the basic blood oxygen saturation, the blood oxygen saturation net recovery time and the blood perfusion index increase; when the vascular endothelial function abnormality index is greater than an abnormality index threshold, determining that the target user has vascular endothelial dysfunction.
Description
技术领域Technical Field
本公开涉及数据处理技术领域,尤其涉及一种微血管内皮功能检测方法、装置、电子设备及存储介质。The present disclosure relates to the field of data processing technology, and in particular to a microvascular endothelial function detection method, device, electronic equipment and storage medium.
背景技术Background Art
血管内皮细胞是覆盖于血管最内壁的单细胞层,是人体最重要的代谢和内分泌器官之一。成人约有1012个内皮细胞,覆盖在400~500 m2的血管内腔表面。内皮细胞是血管壁和血管腔的机械与生物学屏障,除维持血管壁的完整和内表面的光滑以外,还具有调节血管的通透性和张力、抗炎、抗氧化、抑制增殖、维持凝血、抗凝及纤溶平衡以及促进新生血管形成等,故对维持血管的稳态具有重要作用。尽管血管内皮细胞有较强的修复能力,但在心血管危险因素、药物、微生物、免疫反应和炎症的持续作用下,内皮细胞对血管的保护作用减弱或消失,称为内皮功能障碍,表现为血管舒张不足、血小板聚集、炎性细胞浸润、甚至血栓形成等。内皮功能障碍与心脑血管病、肾脏疾病、先兆子痫、骨关节疾病等多种疾病的发生和发展存在密切的关联。特别是存在脑血管疾病的病人伴随年龄增长,发生血管性痴呆的风险增加,造成出现老年综合征等严重影响生活质量的一系列疾病。血管内皮功能障碍被证实为心脑血管事件的独立预测因子,是临床上可测得的动脉粥样硬化性血管损伤最早期的指标。血管内皮功能检测可以作为心脑血管危险分层的可靠指标,无论对于一级预防还是二级预防均有着重要的意义。Endothelial cells are a single cell layer covering the innermost wall of blood vessels and are one of the most important metabolic and endocrine organs in the human body. An adult has about 10 12 endothelial cells, covering 400 to 500 m2 of the vascular lumen surface. Endothelial cells are the mechanical and biological barrier between the vascular wall and the lumen. In addition to maintaining the integrity of the vascular wall and the smoothness of the inner surface, they also have the functions of regulating vascular permeability and tension, anti-inflammatory, antioxidant, inhibiting proliferation, maintaining the balance of coagulation, anticoagulation and fibrinolysis, and promoting the formation of new blood vessels. Therefore, they play an important role in maintaining vascular homeostasis. Although endothelial cells have a strong repair ability, under the continuous action of cardiovascular risk factors, drugs, microorganisms, immune response and inflammation, the protective effect of endothelial cells on blood vessels is weakened or disappears, which is called endothelial dysfunction, which is manifested as insufficient vasodilation, platelet aggregation, inflammatory cell infiltration, and even thrombosis. Endothelial dysfunction is closely related to the occurrence and development of many diseases such as cardiovascular and cerebrovascular diseases, kidney diseases, preeclampsia, and bone and joint diseases. In particular, patients with cerebrovascular diseases have an increased risk of vascular dementia as they age, resulting in a series of diseases such as geriatric syndrome that seriously affect the quality of life. Endothelial dysfunction has been confirmed to be an independent predictor of cardiovascular and cerebrovascular events and is the earliest clinically measurable indicator of atherosclerotic vascular damage. Endothelial function testing can be used as a reliable indicator for cardiovascular and cerebrovascular risk stratification, which is of great significance for both primary and secondary prevention.
相关技术中,广泛采用外周动脉张力测量(Peripheral Arterial Tonometry,PAT)微血管内皮功能。例如,采用EndoPAT软件对闭塞前后信号幅度比值进行自动分析,得出内皮功能评估指数(Reactive Hyperemia Index,RHI)。根据内皮功能评估指数判断内皮功能是否存在障碍,RHI数值越高,提示内皮功能越好,当RHI≤1.67 提示内皮功能障碍。然而,现有检测微血管内皮功能的技术需要采用EndoPAT仪器测量反应性充血指数,而使用EndoPAT仪器会使得整个检测过程耗时较多,从而导致检测效率较低。因此,如何提高检测效率是当前亟需解决的问题。Among the related technologies, peripheral arterial tonometry (PAT) is widely used to measure microvascular endothelial function. For example, the EndoPAT software is used to automatically analyze the signal amplitude ratio before and after occlusion to obtain the endothelial function assessment index (Reactive Hyperemia Index, RHI). The endothelial function assessment index is used to determine whether there is endothelial function disorder. The higher the RHI value, the better the endothelial function. When RHI ≤ 1.67, it indicates endothelial dysfunction. However, the existing technology for detecting microvascular endothelial function requires the use of the EndoPAT instrument to measure the reactive hyperemia index, and the use of the EndoPAT instrument will make the entire detection process time-consuming, resulting in low detection efficiency. Therefore, how to improve the detection efficiency is an urgent problem that needs to be solved.
发明内容Summary of the invention
为了解决上述技术问题或者至少部分地解决上述技术问题,本公开提供了一种微血管内皮功能检测方法,解决了现有技术中检测微血管内皮功能效率低、检测成本高的技术问题。In order to solve the above technical problems or at least partially solve the above technical problems, the present disclosure provides a method for detecting microvascular endothelial function, which solves the technical problems of low efficiency and high detection cost of microvascular endothelial function detection in the prior art.
为了实现上述目的,本公开实施例提供技术方案如下:In order to achieve the above objectives, the embodiments of the present disclosure provide the following technical solutions:
第一方面,本公开的实施例提供一种微血管内皮功能检测方法,所述方法包括:In a first aspect, an embodiment of the present disclosure provides a method for detecting microvascular endothelial function, the method comprising:
获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值;Obtain the target user's basic blood oxygen saturation, blood oxygen saturation net recovery time, and blood perfusion index increase value;
根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数;Determining a vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value;
当所述血管内皮功能异常指数大于异常指数阈值时,确定所述目标用户存在血管内皮功能障碍。When the vascular endothelial dysfunction index is greater than the abnormal index threshold, it is determined that the target user has vascular endothelial dysfunction.
作为本公开实施例一种可选的实施方式,所述获取目标用户的基础血氧饱和度净恢复时间,包括:As an optional implementation of the embodiment of the present disclosure, the obtaining of the basic blood oxygen saturation net recovery time of the target user includes:
记录所述目标用户的血氧饱和度由第一血氧饱和度恢复到第二血氧饱和度的时间为第一时长;所述第一血氧饱和度用于表示所述目标用户在肱动脉血流阻断预设时长时的血氧饱和度,所述第二血氧饱和度基于所述基础血氧饱和度乘以预设系数得到;The time for the target user's blood oxygen saturation to recover from the first blood oxygen saturation to the second blood oxygen saturation is recorded as a first duration; the first blood oxygen saturation is used to represent the blood oxygen saturation of the target user when the brachial artery blood flow is blocked for a preset duration, and the second blood oxygen saturation is obtained based on the basic blood oxygen saturation multiplied by a preset coefficient;
记录从所述目标用户的肱动脉血流被阻断时到恢复脉搏的时间为第二时长;Recording the time from when the brachial artery blood flow of the target user is blocked to when the pulse is restored as the second duration;
将所述第一时长与所述第二时长进行做差运算,获取所述血氧饱和度净恢复时间。A difference operation is performed between the first time length and the second time length to obtain the blood oxygen saturation net recovery time.
作为本公开实施例一种可选的实施方式,所述获取目标用户的血流灌注指数增加值,包括:As an optional implementation of the embodiment of the present disclosure, the step of obtaining the blood perfusion index increase value of the target user includes:
获取所述目标用户的基础血流灌注指数和第一血流灌注指数;所述第一血流灌注指数为所述目标用户的肱动脉血流被阻断到恢复脉搏的过程中最大的血流灌注指数;Acquire a basic blood perfusion index and a first blood perfusion index of the target user; the first blood perfusion index is the maximum blood perfusion index of the target user during the process from when the brachial artery blood flow is blocked to when the pulse is restored;
根据所述第一血流灌注指数和所述基础血流灌注指数,确定所述血流灌注指数增加值。The blood perfusion index increase value is determined according to the first blood perfusion index and the basic blood perfusion index.
作为本公开实施例一种可选的实施方式,当所述血管内皮功能异常指数大于异常指数阈值时,确定所述目标用户存在血管内皮功能障碍之前,所述方法还包括:As an optional implementation of the embodiment of the present disclosure, when the vascular endothelial dysfunction index is greater than the abnormal index threshold, before determining that the target user has vascular endothelial dysfunction, the method further includes:
根据目标用户人群的属性,对所述目标用户人群进行分类;Classifying the target user population according to the attributes of the target user population;
针对不同的目标用户人群,确定不同目标用户人群对应的异常指数阈值。For different target user groups, determine the abnormal index thresholds corresponding to different target user groups.
作为本公开实施例一种可选的实施方式,所述根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数,包括:As an optional implementation of the embodiment of the present disclosure, determining the vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value includes:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
作为本公开实施例一种可选的实施方式,当所述目标用户的年龄大于等于第一预设年龄时,所述根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数,包括:As an optional implementation of the embodiment of the present disclosure, when the age of the target user is greater than or equal to a first preset age, determining the vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value includes:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
作为本公开实施例一种可选的实施方式,当所述目标用户的年龄大于等于第二预设年龄,且小于所述第一预设年龄时,所述根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数,包括:As an optional implementation of the embodiment of the present disclosure, when the age of the target user is greater than or equal to a second preset age and less than the first preset age, determining the vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value includes:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
第二方面,本公开实施例提供一种微血管内皮功能检测装置,包括:In a second aspect, the present disclosure provides a microvascular endothelial function detection device, comprising:
获取模块,用于获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值;An acquisition module is used to obtain the target user's basic blood oxygen saturation, blood oxygen saturation net recovery time, and blood perfusion index increase value;
计算模块,用于根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数;A calculation module, used for determining a vascular endothelial dysfunction index according to the basic blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value;
确定模块,用于当所述血管内皮功能异常指数大于异常指数阈值时,确定所述目标用户存在血管内皮功能障碍。The determination module is used to determine that the target user has endothelial dysfunction when the endothelial dysfunction index is greater than an abnormal index threshold.
作为本公开实施例一种可选的实施方式,所述获取模块,具体用于:As an optional implementation of the embodiment of the present disclosure, the acquisition module is specifically used to:
记录所述目标用户的血氧饱和度由第一血氧饱和度恢复到第二血氧饱和度的时间为第一时长;所述第一血氧饱和度用于表示所述目标用户在肱动脉血流阻断预设时长时的血氧饱和度,所述第二血氧饱和度基于所述基础血氧饱和度乘以预设系数得到;The time for the target user's blood oxygen saturation to recover from the first blood oxygen saturation to the second blood oxygen saturation is recorded as a first duration; the first blood oxygen saturation is used to represent the blood oxygen saturation of the target user when the brachial artery blood flow is blocked for a preset duration, and the second blood oxygen saturation is obtained based on the basic blood oxygen saturation multiplied by a preset coefficient;
记录从所述目标用户的肱动脉血流被阻断时到恢复脉搏的时间为第二时长;Recording the time from when the brachial artery blood flow of the target user is blocked to when the pulse is restored as the second duration;
将所述第一时长与所述第二时长进行做差运算,获取所述血氧饱和度净恢复时间。A difference operation is performed between the first time length and the second time length to obtain the blood oxygen saturation net recovery time.
作为本公开实施例一种可选的实施方式,所述获取模块,具体用于:As an optional implementation of the embodiment of the present disclosure, the acquisition module is specifically used to:
获取所述目标用户的基础血流灌注指数和第一血流灌注指数;所述第一血流灌注指数为所述目标用户的肱动脉血流被阻断到恢复脉搏的过程中最大的血流灌注指数;Acquire a basic blood perfusion index and a first blood perfusion index of the target user; the first blood perfusion index is the maximum blood perfusion index of the target user during the process from when the brachial artery blood flow is blocked to when the pulse is restored;
根据所述第一血流灌注指数和所述基础血流灌注指数,确定所述血流灌注指数增加值。The blood perfusion index increase value is determined according to the first blood perfusion index and the basic blood perfusion index.
作为本公开实施例一种可选的实施方式,所述装置还包括:As an optional implementation of the embodiment of the present disclosure, the device further includes:
分类模块,用于根据目标用户人群的属性,对所述目标用户人群进行分类;A classification module, used to classify the target user population according to the attributes of the target user population;
阈值确定模块,用于针对不同的目标用户人群,确定不同目标用户人群对应的异常指数阈值。The threshold determination module is used to determine the abnormal index thresholds corresponding to different target user groups.
作为本公开实施例一种可选的实施方式,所述计算模块,具体用于:As an optional implementation of the embodiment of the present disclosure, the computing module is specifically used for:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
作为本公开实施例一种可选的实施方式,当所述目标用户的年龄大于等于第一预设年龄时,所述计算模块,具体用于:As an optional implementation of the embodiment of the present disclosure, when the age of the target user is greater than or equal to a first preset age, the calculation module is specifically configured to:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
作为本公开实施例一种可选的实施方式,当所述目标用户的年龄大于等于第二预设年龄,且小于所述第一预设年龄时,所述计算模块,具体用于:As an optional implementation of the embodiment of the present disclosure, when the age of the target user is greater than or equal to a second preset age and less than the first preset age, the calculation module is specifically configured to:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
第三方面,本公开实施例提供一种电子设备,包括存储器和处理器,所述存储器存储有计算机程序,所述处理器执行所述计算机程序时实现上述第一方面或第一方面的任一实施方式所述的微血管内皮功能检测方法。In a third aspect, an embodiment of the present disclosure provides an electronic device, comprising a memory and a processor, wherein the memory stores a computer program, and when the processor executes the computer program, the microvascular endothelial function detection method described in the first aspect or any embodiment of the first aspect is implemented.
第四方面,本公开实施例提供一种计算机可读存储介质,其上存储有计算机程序,计算机程序被处理器执行时实现上述第一方面或第一方面的任一实施方式所述的微血管内皮功能检测方法。In a fourth aspect, an embodiment of the present disclosure provides a computer-readable storage medium having a computer program stored thereon. When the computer program is executed by a processor, the microvascular endothelial function detection method described in the first aspect or any embodiment of the first aspect is implemented.
本公开提供的微血管内皮功能检测方法,获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值,根据基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值,确定血管内皮功能异常指数,当血管内皮功能异常指数大于异常指数阈值时,确定目标用户存在血管内皮功能障碍。可见,本公开实施例可以在获取到目标用户的检查信息,即获取到基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值后,通过检查信息由计算机自动确定目标用户是否存在血管内皮功能障碍,无需采用EndoPAT仪器,提高了检测效率。The microvascular endothelial function detection method provided by the present disclosure obtains the target user's basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value, determines the abnormal endothelial function index according to the basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value, and determines that the target user has endothelial dysfunction when the abnormal endothelial function index is greater than the abnormal index threshold. It can be seen that the embodiment of the present disclosure can automatically determine whether the target user has endothelial dysfunction through the computer through the inspection information after obtaining the inspection information of the target user, that is, obtaining the basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value, without using the EndoPAT instrument, thereby improving the detection efficiency.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
此处的附图被并入说明书中并构成本说明书的一部分,示出了符合本公开的实施例,并与说明书一起用于解释本公开的原理。The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the present disclosure and, together with the description, serve to explain the principles of the present disclosure.
为了更清楚地说明本公开实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,对于本领域普通技术人员而言,在不付出创造性劳动性的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.
图1为本公开实施例中微血管内皮功能检测方法的流程示意图;FIG1 is a schematic diagram of a process for detecting microvascular endothelial function in an embodiment of the present disclosure;
图2为本公开实施例中微血管内皮功能检测装置的结构示意图;FIG2 is a schematic diagram of the structure of a microvascular endothelial function detection device in an embodiment of the present disclosure;
图3为本公开实施例所述的电子设备的结构示意图。FIG. 3 is a schematic diagram of the structure of an electronic device according to an embodiment of the present disclosure.
具体实施方式DETAILED DESCRIPTION
为了能够更清楚地理解本公开的上述目的、特征和优点,下面将对本公开的方案进行进一步描述。需要说明的是,在不冲突的情况下,本公开的实施例及实施例中的特征可以相互组合。In order to more clearly understand the above-mentioned objectives, features and advantages of the present disclosure, the scheme of the present disclosure will be further described below. It should be noted that the embodiments of the present disclosure and the features in the embodiments can be combined with each other without conflict.
在下面的描述中阐述了很多具体细节以便于充分理解本公开,但本公开还可以采用其他不同于在此描述的方式来实施;显然,说明书中的实施例只是本公开的一部分实施例,而不是全部的实施例。In the following description, many specific details are set forth to facilitate a full understanding of the present disclosure, but the present disclosure may also be implemented in other ways different from those described herein; it is obvious that the embodiments in the specification are only part of the embodiments of the present disclosure, rather than all of the embodiments.
本公开的说明书和权利要求书中的术语“第一”和“第二”等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。Relational terms such as “first” and “second” in the description and claims of the present disclosure are merely used to distinguish one entity or operation from another entity or operation, but do not necessarily require or imply any such actual relationship or order between these entities or operations.
在本公开实施例中,“示例性的”或者“例如”等词是用于表示作例子、例证或说明。本公开实施例中被描述为“示例性的”或者“例如”的任何实施例或设计方案不应被解释为比其它实施例或设计方案更优选或更具优势。确切而言,使用“示例性的”或者“例如”等词旨在以具体方式呈现相关概念。此外,在本公开实施例的描述中,除非另有说明,“多个”的含义是指两个或两个以上。In the embodiments of the present disclosure, words such as "exemplary" or "for example" are used to indicate examples, illustrations or descriptions. Any embodiment or design described as "exemplary" or "for example" in the embodiments of the present disclosure should not be interpreted as being more preferred or more advantageous than other embodiments or designs. Specifically, the use of words such as "exemplary" or "for example" is intended to present related concepts in a concrete way. In addition, in the description of the embodiments of the present disclosure, unless otherwise specified, the meaning of "multiple" refers to two or more.
术语解释:Terminology explanation:
EndoPAT:采用PAT外周动脉张力信号技术,进行微循环无创内皮功能检测的设备。EndoPAT: A device that uses PAT peripheral arterial tension signal technology to perform non-invasive endothelial function testing of microcirculation.
RHI(Reactive Hyperemia index): 外周动脉反应性充血指数,采用EndoPAT进行微血管内皮功能测定过程中,RHI反映了内皮细胞介导的舒张效应。如果RHI≤1.67,表示其内皮功能障碍。RHI (Reactive Hyperemia index): Peripheral artery reactive hyperemia index. During the measurement of microvascular endothelial function using EndoPAT, RHI reflects the endothelial cell-mediated relaxation effect. If RHI ≤ 1.67, it indicates endothelial dysfunction.
:血氧饱和度,是指血液中氧气与血红蛋白结合的比例,通常用百分比表示。 :Blood oxygen saturation refers to the ratio of oxygen combined with hemoglobin in the blood, usually expressed as a percentage.
PI(Perfusion Index):血流灌注指数,是指皮肤组织中的血流量相对于皮肤组织的容积的比例。PI值越高,表示皮肤组织中的血流量越大,血液供应越充足。PI (Perfusion Index): Blood perfusion index refers to the ratio of blood flow in skin tissue to the volume of skin tissue. The higher the PI value, the greater the blood flow in the skin tissue and the more adequate the blood supply.
现有技术中,采用EndoPAT软件对闭塞前后信号幅度比值进行自动分析,得出内皮功能评估指数(Reactive Hyperemia Index,RHI)。外周动脉张力测定通过手指探头的压力感受器测量阻断肱动脉血流前后指尖张力的变化来反映微血管反应性充血的程度,EndoPAT对内皮介导的血管张力变化进行量化,通过5分钟的肱动脉短暂闭塞(使用标准的血压袖带)来获取这个变化信息。当袖带被松开时,血流冲击引起内皮依赖性舒张。这种扩张表现为反应性充血,它可以被EndoPAT捕获,表现为PAT信号幅度增强。采用EndoPAT软件对闭塞前后信号幅度比值进行自动分析,得出内皮功能评估指数(Reactive HyperemiaIndex,RHI)。EndoPAT具体操作如下:在室温21-24℃的环境下,打开EndoPAT系统,预热至少20分钟。患者安静地平卧或坐位15分钟,使心血管恢复稳态并调整到室温,将EndoPAT传感器嵌套于双手食指前端,其中一侧检测内皮功能,另一侧作为对照监测全身性血管变化。将标准袖带束于测试内皮功能同侧手臂肱动脉上 2cm 处,此时暂不充血,首先采集 5min的基线张力数据,随后袖带充气阻断肱动脉血流 5min 并采集数据,最后将袖带快速放气,利用血流对管壁的剪切力引起内皮依赖性血管舒张,同时采集这一过程中增加的张力信号5min(表现为 PAT 信号幅度增强)。最终由电脑 EndoPAT 软件对阻断前后信号幅度比值进行计算,在根据另一侧对照数据对检测结果进行修正,得出RHI。整个检测过程需要15min。RHI数值越高,提示内皮功能越好,当RHI≤1.67 提示内皮功能障碍。然而,现有检测微血管内皮功能的技术所采用的EndoPAT仪器费用高,需要额外耗材,无法便携式携带,且整个检测过程耗时较多,导致检测效率较低。因此,如何提高检测效率,降低检测成本是当前亟需解决的问题。In the prior art, EndoPAT software is used to automatically analyze the ratio of signal amplitudes before and after occlusion to obtain the Reactive Hyperemia Index (RHI). Peripheral artery tension measurement measures the change in fingertip tension before and after blocking the brachial artery blood flow through the pressure receptors of the finger probe to reflect the degree of microvascular reactive hyperemia. EndoPAT quantifies the change in endothelial-mediated vascular tension and obtains this change information through a 5-minute short-term occlusion of the brachial artery (using a standard blood pressure cuff). When the cuff is released, the blood flow shock causes endothelium-dependent relaxation. This expansion manifests as reactive hyperemia, which can be captured by EndoPAT and manifested as an increase in the amplitude of the PAT signal. EndoPAT software is used to automatically analyze the ratio of signal amplitudes before and after occlusion to obtain the Reactive Hyperemia Index (RHI). The specific operation of EndoPAT is as follows: At room temperature of 21-24°C, turn on the EndoPAT system and preheat for at least 20 minutes. The patient lies or sits quietly for 15 minutes to allow the cardiovascular system to return to steady state and adjust to room temperature. The EndoPAT sensor is embedded in the front end of the index finger of both hands, one side is used to detect endothelial function, and the other side is used as a control to monitor systemic vascular changes. The standard cuff is tied 2 cm above the brachial artery on the same side of the arm where the endothelial function is tested. At this time, there is no congestion. First, 5 minutes of baseline tension data are collected. Then the cuff is inflated to block the brachial artery blood flow for 5 minutes and the data is collected. Finally, the cuff is quickly deflated to use the shear force of blood flow on the vessel wall to cause endothelial-dependent vasodilation. At the same time, the tension signal increased in this process is collected for 5 minutes (manifested as an increase in the amplitude of the PAT signal). Finally, the computer EndoPAT software calculates the ratio of the signal amplitude before and after the blockade, and then corrects the test results according to the control data on the other side to obtain the RHI. The entire test process takes 15 minutes. The higher the RHI value, the better the endothelial function. When RHI ≤ 1.67, it indicates endothelial dysfunction. However, the EndoPAT instrument used in the existing technology for testing microvascular endothelial function is expensive, requires additional consumables, is not portable, and the entire testing process is time-consuming, resulting in low testing efficiency. Therefore, how to improve testing efficiency and reduce testing costs is an urgent problem to be solved.
针对上述问题,本公开实施例提供一种微血管内皮功能检测方法,获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值,根据基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值,确定血管内皮功能异常指数,当血管内皮功能异常指数大于异常指数阈值时,确定目标用户存在血管内皮功能障碍。可见,本公开实施例可以在获取到目标用户的检查信息,即获取到基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值后,通过检测信息由计算机自动确定目标用户是否存在血管内皮功能障碍,避免采用EndoPAT仪器导致整个检测过程耗时较多,从而提高了检测效率,同时,由于整个检测过程不用使用昂贵的EndoPAT仪器测量反应性充血指数,所以可以降低检测成本。In view of the above problems, the embodiment of the present disclosure provides a microvascular endothelial function detection method, which obtains the basic blood oxygen saturation, the net recovery time of blood oxygen saturation and the increase of blood perfusion index of the target user, determines the abnormal endothelial function index according to the basic blood oxygen saturation, the net recovery time of blood oxygen saturation and the increase of blood perfusion index, and determines that the target user has endothelial dysfunction when the abnormal endothelial function index is greater than the abnormal index threshold. It can be seen that the embodiment of the present disclosure can automatically determine whether the target user has endothelial dysfunction through the detection information after obtaining the inspection information of the target user, that is, obtaining the basic blood oxygen saturation, the net recovery time of blood oxygen saturation and the increase of blood perfusion index, thereby avoiding the use of EndoPAT instrument to cause the entire detection process to be more time-consuming, thereby improving the detection efficiency. At the same time, since the entire detection process does not use the expensive EndoPAT instrument to measure the reactive hyperemia index, the detection cost can be reduced.
在一个实施例中,如图1所示,提供一种微血管内皮功能检测方法,包括如下步骤S11- S13:In one embodiment, as shown in FIG1 , a method for detecting microvascular endothelial function is provided, comprising the following steps S11-S13:
S11、获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值。S11. Obtain the target user's basic blood oxygen saturation, blood oxygen saturation net recovery time, and blood perfusion index increase value.
其中,基础血氧饱和度是指目标用户在空腹状态下取坐位,一侧手臂自然放松平放在桌面上,血压计袖带绑于同侧上臂肘窝上方2-3cm,掌心朝下,整个检测过程中手和腕部保持不动,应用指氧仪测量同侧手指得到的血氧饱和度()。在正常情况下,动脉血的血氧饱和度的参考值为95%-100%。如果动脉血流被阻断,血氧饱和度会因为组织消耗氧气而逐渐降低。Among them, the basic blood oxygen saturation refers to the target user sitting in an empty stomach state, with one arm naturally relaxed and flat on the table, and the blood pressure cuff tied 2-3cm above the elbow of the upper arm on the same side, with the palm facing down. The hand and wrist remain motionless during the entire test, and the finger oximeter is used to measure the blood oxygen saturation of the finger on the same side ( ). Under normal circumstances, the reference value of arterial blood oxygen saturation is 95%-100%. If arterial blood flow is blocked, blood oxygen saturation will gradually decrease due to tissue oxygen consumption.
血氧饱和度净恢复时间是指在一段时间的低氧状态后,血氧饱和度恢复到正常水平所需的时间。The net recovery time of blood oxygen saturation refers to the time required for blood oxygen saturation to return to normal levels after a period of low oxygen.
血流灌注指数(Perfusion Index, PI)是一个通过脉搏指氧计测量得到的数值,它反映了外周组织中脉动血流与非脉动血流的比率,即动脉血流的灌注能力。正常情况下,PI值通常介于4-5之间。PI值的高低受多种因素影响,包括测量方法、测量部位、环境温度等。血流灌注指数增加值可以通过血流灌注指数计算得到。同样地,目标用户在空腹状态下取坐位,一侧手臂自然放松平放在桌面上,血压计袖带绑于同侧上臂肘窝上方2-3cm,掌心朝下,整个检测过程中手和腕部保持不动,应用指氧仪测量同侧手指可以得到血流灌注指数。The perfusion index (PI) is a value measured by a pulse oximeter, which reflects the ratio of pulsating blood flow to non-pulsating blood flow in peripheral tissues, that is, the perfusion capacity of arterial blood flow. Under normal circumstances, the PI value is usually between 4 and 5. The PI value is affected by many factors, including the measurement method, measurement site, ambient temperature, etc. The increase in the perfusion index can be calculated by the perfusion index. Similarly, the target user sits in a fasting state, with one arm naturally relaxed and flat on the table, the blood pressure cuff is tied 2-3 cm above the elbow of the upper arm on the same side, with the palm facing down, and the hand and wrist remain motionless during the entire test. The perfusion index can be obtained by measuring the finger on the same side with the oximeter.
血流灌注指数(PI)的测量方法:要获取血流灌注指数(Perfusion Index,简称PI),通常可以通过脉搏血氧饱和度监测设备来测量。PI是从脉搏血氧饱和度()读数中得出的数值,它反映了传感器部位的脉搏强度,是监测部位血液流动的指标,可以帮助评估身体的循环效率。PI的计算公式是 PI = (PS/NS) × 100,其中PS代表脉动信号(AC),NS代表非脉动信号(DC)。Measurement method of blood perfusion index (PI): To obtain blood perfusion index (PI), it can usually be measured by pulse oximetry monitoring equipment. PI is a measure of the blood perfusion index ( ) readings, which reflects the pulse strength at the sensor site and is an indicator of blood flow at the monitoring site, which can help assess the body's circulatory efficiency. The PI calculation formula is PI = (PS/NS) × 100, where PS represents the pulsating signal (AC) and NS represents the non-pulsating signal (DC).
在一些实施例中,上述步骤S11(获取血氧饱和度净恢复时间)可以通过如下方式实现:In some embodiments, the above step S11 (obtaining the net recovery time of blood oxygen saturation) can be implemented in the following manner:
(1)、记录所述目标用户的血氧饱和度由第一血氧饱和度恢复到第二血氧饱和度的时间为第一时长。(1) Recording the time it takes for the target user's blood oxygen saturation to recover from the first blood oxygen saturation to the second blood oxygen saturation as a first duration.
其中,所述第一血氧饱和度用于表示所述目标用户在肱动脉血流阻断预设时长时的血氧饱和度,所述第二血氧饱和度基于所述基础血氧饱和度乘以预设系数得到。The first blood oxygen saturation is used to represent the blood oxygen saturation of the target user when the brachial artery blood flow is blocked for a preset time, and the second blood oxygen saturation is obtained based on the basic blood oxygen saturation multiplied by a preset coefficient.
其中,预设系数可以取95%。Among them, the preset coefficient can be 95%.
(2)、记录从所述目标用户的肱动脉血流被阻断时到恢复脉搏的时间为第二时长。(2) Recording the time from when the brachial artery blood flow of the target user is blocked to when the pulse is restored as the second time duration.
具体的,肱动脉血流完全阻断是通过袖带快速充气至压力高于收缩压60mmHg或血氧饱和度读数消失确定的,当肱动脉血流完全阻断后,持续5分钟,袖带放气,记录指氧仪检测到脉搏时间(即第二时长)、恢复到95%时间(即第一时长)、PI最大值。当肱动脉血流被完全阻断时,理论上该区域的血氧饱和度会显著下降,因为阻断会中断血液流向该区域,导致该区域的组织无法获得足够的氧气。然而,血氧饱和度的具体数值会受到多种因素的影响,包括阻断的时间长度、个体的健康状况、是否有其他循环途径等。Specifically, complete blockage of brachial artery blood flow was determined by rapid inflation of the cuff to a pressure higher than 60 mmHg of systolic blood pressure or disappearance of the blood oxygen saturation reading. When the brachial artery blood flow was completely blocked for 5 minutes, the cuff was deflated and the pulse time detected by the oximeter was recorded (i.e., the second duration). The time to recover to 95% (i.e. the first duration) and the maximum value of PI. When the brachial artery blood flow is completely blocked, theoretically the blood oxygen saturation in that area will drop significantly, because the blockage will interrupt the blood flow to that area, resulting in the tissue in that area not getting enough oxygen. However, the specific value of blood oxygen saturation will be affected by many factors, including the length of time of blockage, the individual's health status, and whether there are other circulation pathways.
(3)、将所述第一时长与所述第二时长进行做差运算,获取所述血氧饱和度净恢复时间。(3) Performing a difference operation on the first time duration and the second time duration to obtain the net recovery time of the blood oxygen saturation.
具体的,血氧饱和度净恢复时间用于表示目标用户的血氧饱和度由第一血氧饱和度恢复到第二血氧饱和度的时间与目标用户在肱动脉血流阻断预设时长后检测到脉搏的时间之差。通过公式血氧饱和度净恢复时间t=(第一时长-第二时长),计算得到血氧饱和度净恢复时间。Specifically, the blood oxygen saturation net recovery time is used to represent the difference between the time when the target user's blood oxygen saturation recovers from the first blood oxygen saturation to the second blood oxygen saturation and the time when the pulse of the target user is detected after the brachial artery blood flow is blocked for a preset time. The blood oxygen saturation net recovery time is calculated by the formula blood oxygen saturation net recovery time t = (first time - second time).
在一些实施例中,上述步骤S11(获取血流灌注指数增加值)可以通过如下方式实现:In some embodiments, the above step S11 (obtaining the blood perfusion index increase value) can be implemented in the following manner:
a、获取所述目标用户的基础血流灌注指数和第一血流灌注指数。a. Obtaining a basic blood perfusion index and a first blood perfusion index of the target user.
其中,所述第一血流灌注指数为所述目标用户的肱动脉血流被阻断到恢复脉搏的过程中最大的血流灌注指数。The first blood perfusion index is the maximum blood perfusion index during the process from when the brachial artery blood flow of the target user is blocked to when the pulse is restored.
b、根据所述第一血流灌注指数和所述基础血流灌注指数,确定所述血流灌注指数增加值。b. Determine the blood perfusion index increase value according to the first blood perfusion index and the basic blood perfusion index.
通过公式,计算得到血流灌注指数增加值。其中,表示血流灌注指数增加值。By formula , and the increased value of blood perfusion index is calculated. Among them, Indicates the increase in blood perfusion index.
S12、根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数。S12. Determine a vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value.
在一些实施例中,可以根据如下公式计算血管内皮功能异常指数,;In some embodiments, the vascular endothelial dysfunction index can be calculated according to the following formula: ;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
具体的,预实验纳入多例患者,需要说明的是,该多例患者是从全部人群中随机选取的,并没有针对某类特定人群进行筛选。即,当目标用户不属于某类特定人群时,则可以根据上述公式计算血管内皮功能异常指数。基于EndoPAT测量反应性充血指数(reactivehyperemia index,RHI),采用RHI ≤1.67为血管内皮功能障碍的金标准,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算血管内皮功能异常指数(Endothelial dysfunction score, ED score)。Specifically, the pilot experiment included multiple patients. It should be noted that these multiple patients were randomly selected from the entire population and were not screened for a specific population. That is, when the target user does not belong to a specific population, the endothelial dysfunction index can be calculated according to the above formula. Based on EndoPAT measurement of reactive hyperemia index (RHI), RHI ≤ 1.67 was used as the gold standard for endothelial dysfunction. Through multivariate logistic regression, , , Endothelial dysfunction was jointly predicted and the endothelial dysfunction score (ED score) was calculated based on the results of logistic regression.
示例性的,预实验纳入98例患者,平均年龄为60岁,男性比例47.2%。EDscore非正态分布,中位数及四分位数间距为-0.24 (-0.57, 0.27),EDscore最小值为-1.87,EDscore最大值为2.78。通过计算EDscore预测血管内皮功能障碍,ROC曲线下面积(Area Under theCurve,AUC)为0.7,最佳截断值为-0.38。EDscore>-0.38提示内皮功能障碍,判断内皮功能障碍的敏感性为82.6%,特异性为61.5%。For example, the pilot study included 98 patients with an average age of 60 years and a male ratio of 47.2%. The EDscore was not normally distributed, with a median and interquartile range of -0.24 (-0.57, 0.27), a minimum EDscore of -1.87, and a maximum EDscore of 2.78. By calculating the EDscore to predict vascular endothelial dysfunction, the area under the ROC curve (AUC) was 0.7, and the optimal cutoff value was -0.38. EDscore>-0.38 indicates endothelial dysfunction, and the sensitivity of judging endothelial dysfunction is 82.6% and the specificity is 61.5%.
在一些实施例中,当所述目标用户的年龄大于等于第一预设年龄时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the age of the target user is greater than or equal to the first preset age, the above step S12 (determining the vascular endothelial dysfunction index according to the basic blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,以第一预设年龄为60岁进行举例说明,预实验纳入98例患者,60岁以上老年人共52人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为0.120(-0.474, 0.623) , EDscore最小值为-1.43,EDscore最大值为3.02,通过EDscore预测内皮功能障碍,AUC=0.716,最佳截断值为-0.029,判断内皮功能障碍的敏感性为77.8%,特异性为68%。In the embodiment of the present disclosure, the first preset age is 60 years old for example. A preliminary experiment includes 98 patients, 52 of whom are elderly people over 60 years old. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of 0.120 (-0.474, 0.623), a minimum EDscore of -1.43, and a maximum EDscore of 3.02. The AUC for predicting endothelial dysfunction by EDscore was 0.716, with an optimal cutoff value of -0.029. The sensitivity of judging endothelial dysfunction was 77.8%, and the specificity was 68%.
在一些实施例中,当所述目标用户的年龄大于等于第二预设年龄,且小于所述第一预设年龄时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the age of the target user is greater than or equal to the second preset age and less than the first preset age, the above step S12 (determining the vascular endothelial dysfunction index according to the basic blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,以第一预设年龄为60岁,第二预设年龄为45岁进行举例说明,预实验纳入98例患者,其中,年龄在45岁到60岁之间的人有38人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为-0.885 (-1.360,-0.447) ,EDscore最小值为-2.38,EDscore最大值为2.03,通过EDscore预测内皮功能障碍,AUC=0.705,最佳截断值为-0.735,判断内皮功能障碍的敏感性为66.7%,特异性为73.1%。In the embodiment of the present disclosure, the first preset age is 60 years old and the second preset age is 45 years old. The pilot experiment includes 98 patients, of which 38 are between 45 and 60 years old. Through multivariate logistic regression, the , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of -0.885 (-1.360, -0.447), a minimum EDscore of -2.38, and a maximum EDscore of 2.03. The AUC for predicting endothelial dysfunction by EDscore was 0.705, with an optimal cutoff value of -0.735. The sensitivity of judging endothelial dysfunction was 66.7%, and the specificity was 73.1%.
在一些实施例中,当所述目标用户为男性时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the target user is a male, the above step S12 (determining the vascular endothelial dysfunction index according to the basic blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,预实验纳入98例患者,其中,男性人数为63人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为-0.386 (-0.877, 0.020) ,EDscore最小值为-2.18,EDscore最大值为3.79,通过EDscore预测内皮功能障碍,AUC=0.728,最佳截断值为-0.495,判断内皮功能障碍的敏感性为85.2%,特异性为61.1%。In the present embodiment, the pilot experiment included 98 patients, of which 63 were males. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of logistic regression. EDscore was not normally distributed, with a median and interquartile range of -0.386 (-0.877, 0.020), a minimum EDscore of -2.18, and a maximum EDscore of 3.79. The AUC for predicting endothelial dysfunction by EDscore was 0.728, with an optimal cutoff value of -0.495. The sensitivity of judging endothelial dysfunction was 85.2%, and the specificity was 61.1%.
在一些实施例中,当所述目标用户为女性时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the target user is a female, the above step S12 (determining the vascular endothelial dysfunction index according to the basic blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,预实验纳入98例患者,其中,女性人数为35人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为0.322 (-0.207,0.636) ,EDscore最小值为-2.69,EDscore最大值为1.43,通过EDscore预测内皮功能障碍,AUC=0.628,最佳截断值为-0.090,判断内皮功能障碍的敏感性为89.5%,特异性为50.0%。In the present embodiment, the pilot experiment included 98 patients, of which 35 were female. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of 0.322 (-0.207, 0.636), a minimum EDscore of -2.69, and a maximum EDscore of 1.43. The AUC for predicting endothelial dysfunction by EDscore was 0.628, with an optimal cutoff value of -0.090. The sensitivity of judging endothelial dysfunction was 89.5%, and the specificity was 50.0%.
在一些实施例中,当所述目标用户为高血压患者时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the target user is a patient with hypertension, the above step S12 (determining the vascular endothelial dysfunction index according to the basic blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,预实验纳入98例患者,其中,患有高血压的人数为63人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为-0.464(-0.959,0.232) ,EDscore最小值为-2.00,EDscore最大值为3.08,通过EDscore预测内皮功能障碍,AUC=0.736,最佳截断值为-0.282,判断内皮功能障碍的敏感性为69.2%,特异性为81.1%。In the present embodiment, the pilot experiment included 98 patients, of whom 63 had hypertension. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of -0.464 (-0.959, 0.232), a minimum EDscore of -2.00, and a maximum EDscore of 3.08. The AUC for predicting endothelial dysfunction by EDscore was 0.736, with an optimal cutoff value of -0.282. The sensitivity of judging endothelial dysfunction was 69.2%, and the specificity was 81.1%.
在一些实施例中,当所述目标用户为非高血压患者时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the target user is a non-hypertensive patient, the above step S12 (determining the vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,预实验纳入98例患者,其中,未患有高血压的人数为35人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为0.259(-0.147,0.871) ,EDscore最小值为-1.31,EDscore最大值为2.62,通过EDscore预测内皮功能障碍,AUC=0.707,最佳截断值为0.186,判断内皮功能障碍的敏感性为75.0%,特异性为60.0%。In the present embodiment, the pilot experiment included 98 patients, of whom 35 did not suffer from hypertension. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of 0.259 (-0.147, 0.871), a minimum EDscore of -1.31, and a maximum EDscore of 2.62. The AUC for predicting endothelial dysfunction by EDscore was 0.707, and the optimal cutoff value was 0.186. The sensitivity of judging endothelial dysfunction was 75.0%, and the specificity was 60.0%.
在一些实施例中,当所述目标用户为糖尿病患者时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the target user is a diabetic patient, the above step S12 (determining the vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,预实验纳入98例患者,其中,患有糖尿病的人数为35人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为-0.058(-0.553,0.102) ,EDscore最小值为-1.41,EDscore最大值为1.71,通过EDscore预测内皮功能障碍,AUC=0.661,最佳截断值为0.138,判断内皮功能障碍的敏感性为75.0%,特异性为57.9%。In the present embodiment, the pilot experiment included 98 patients, of whom 35 had diabetes. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of -0.058 (-0.553, 0.102), a minimum EDscore of -1.41, and a maximum EDscore of 1.71. The AUC for predicting endothelial dysfunction by EDscore was 0.661, and the optimal cutoff value was 0.138. The sensitivity of judging endothelial dysfunction was 75.0%, and the specificity was 57.9%.
在一些实施例中,当所述目标用户为非糖尿病患者时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the target user is a non-diabetic patient, the above step S12 (determining the vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,预实验纳入98例患者,其中,未患有糖尿病的人数为63人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为-0.324(-0.634,0.448) ,EDscore最小值为-2.03,EDscore最大值为2.94,通过EDscore预测内皮功能障碍,AUC=0.776,最佳截断值为-0.475,判断内皮功能障碍的敏感性为90.0%,特异性为69.7%。In the present embodiment, the pilot experiment included 98 patients, of whom 63 did not have diabetes. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of -0.324 (-0.634, 0.448), a minimum EDscore of -2.03, and a maximum EDscore of 2.94. The AUC for predicting endothelial dysfunction by EDscore was 0.776, with an optimal cutoff value of -0.475. The sensitivity of judging endothelial dysfunction was 90.0%, and the specificity was 69.7%.
在一些实施例中,当所述目标用户为吸烟人群时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the target user is a smoker, the above step S12 (determining the vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,预实验纳入98例患者,其中,吸烟的人数为41人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为-0.253(-0.734,0.057) ,EDscore最小值为-1.96,EDscore最大值为2.41,通过EDscore预测内皮功能障碍,AUC=0.684,最佳截断值为-0.135,判断内皮功能障碍的敏感性为55.6%,特异性为78.3%。In the present embodiment, the pilot experiment included 98 patients, of whom 41 were smokers. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of -0.253 (-0.734, 0.057), a minimum EDscore of -1.96, and a maximum EDscore of 2.41. The AUC for predicting endothelial dysfunction by EDscore was 0.684, with an optimal cutoff value of -0.135. The sensitivity of judging endothelial dysfunction was 55.6%, and the specificity was 78.3%.
在一些实施例中,当所述目标用户为非吸烟人群时,上述步骤S12(根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数)可以通过如下方式实现:In some embodiments, when the target user is a non-smoker, the above step S12 (determining the vascular endothelial dysfunction index according to the basic blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value) can be implemented as follows:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
在本公开实施例中,预实验纳入98例患者,其中,非吸烟的人数为57人,通过多因素Logistic回归,使用、、联合预测内皮功能障碍,根据Logistic回归结果计算。EDscore非正态分布,中位数及四分位数间距为-0.123(-0.602,0.555) ,EDscore最小值为-2.02,EDscore最大值为2.41,通过EDscore预测内皮功能障碍,AUC=0.724,最佳截断值为-0.350,判断内皮功能障碍的敏感性为89.3%,特异性为62.1%。In the present embodiment, the pilot experiment included 98 patients, of whom 57 were non-smokers. Through multivariate logistic regression, , , The combined prediction of endothelial dysfunction was calculated based on the results of Logistic regression. EDscore was not normally distributed, with a median and interquartile range of -0.123 (-0.602, 0.555), a minimum EDscore of -2.02, and a maximum EDscore of 2.41. The AUC for predicting endothelial dysfunction by EDscore was 0.724, with an optimal cutoff value of -0.350. The sensitivity of judging endothelial dysfunction was 89.3%, and the specificity was 62.1%.
在一些实施例中,执行上述步骤S13(当所述血管内皮功能异常指数大于异常指数阈值时,确定所述目标用户存在血管内皮功能障碍)之前,还可以执行如下步骤:In some embodiments, before executing the above step S13 (when the vascular endothelial dysfunction index is greater than the abnormal index threshold, determining that the target user has vascular endothelial dysfunction), the following steps may also be executed:
根据目标用户人群的属性,对所述目标用户人群进行分类;Classifying the target user population according to the attributes of the target user population;
针对不同的目标用户人群,确定不同目标用户人群对应的异常指数阈值。For different target user groups, determine the abnormal index thresholds corresponding to different target user groups.
其中,目标用户人群的属性可以是性别、年龄、是否患有某种慢性疾病等。Among them, the attributes of the target user group can be gender, age, whether or not they suffer from a certain chronic disease, etc.
具体的,通过Logistic回归分析方法,将患者的重要临床特征取值转换成风险评分,从而根据评分确定某种患病情况的风险概率。基于ROC曲线(receiver operatingcharacteristics curve,接受者操作特征曲线)对多因素Logistic回归模型进行模型评价,绘制ROC曲线,确定最佳截断值(在本公开实施例中,最佳截断值即异常指数阈值)。其中,AUC(Area Under Curve,曲线下面积,为ROC曲线下与坐标轴围成的面积)越接近1.0,检测方法的真实性越高。ROC曲线越靠近左上角,模型的准确性就越高。最靠近左上角的ROC曲线上的点是分类错误最少的最好阈值,其假正例和假反例总数最少。通过绘制ROC曲线,可以找到一个点,该点对应的敏感度和特异度之和最大,这个点通常被认为是最佳截断值。敏感度(真阳性率)和特异性(真阴性率)的平衡是通过计算约登指数(Youden Index,即通过将测试的敏感度和特异性相加,然后从总和中减去1来计算得出)来衡量的,约登指数最大的点即为最佳截断值。最佳截断值的确定可以最大程度上正确识别出阳性结果,同时避免将阴性结果误判为阳性。Specifically, through the Logistic regression analysis method, the patient's important clinical characteristics are converted into risk scores, so as to determine the risk probability of a certain disease condition based on the score. The multi-factor Logistic regression model is evaluated based on the ROC curve (receiver operating characteristics curve), the ROC curve is drawn, and the optimal cutoff value (in the present embodiment, the optimal cutoff value is the abnormal index threshold) is determined. Among them, the closer the AUC (Area Under Curve, the area under the curve, is the area under the ROC curve and the coordinate axis) is to 1.0, the higher the authenticity of the detection method. The closer the ROC curve is to the upper left corner, the higher the accuracy of the model. The point on the ROC curve closest to the upper left corner is the best threshold with the least classification error, and its total number of false positives and false negatives is the least. By drawing the ROC curve, a point can be found, and the sum of the sensitivity and specificity corresponding to the point is the largest. This point is usually considered to be the optimal cutoff value. The balance between sensitivity (true positive rate) and specificity (true negative rate) is measured by calculating the Youden Index (calculated by adding the sensitivity and specificity of the test and then subtracting 1 from the sum), and the point with the maximum Youden Index is the optimal cutoff value. The optimal cutoff value is determined to maximize the correct identification of positive results while avoiding misclassification of negative results as positive.
示例性的,将Logistic回归模型中的每个阈值切点的假阳性率(在本公开实施例中即1-特异度)和真阳性率(在本公开实施例中即敏感度)绘制在一个向量图中,即可获得特定模型的ROC曲线。即在每个选定的阈值切点下,都可以计算出一个假阳性率和真阳性率,然后将该假阳性率(x轴)和真阳性率(y轴)绘制在一个向量图中。Exemplarily, the false positive rate (i.e., 1-specificity in the disclosed embodiment) and the true positive rate (i.e., sensitivity in the disclosed embodiment) of each threshold cut-off point in the Logistic regression model are plotted in a vector graph to obtain the ROC curve of the specific model. That is, at each selected threshold cut-off point, a false positive rate and a true positive rate can be calculated, and then the false positive rate (x-axis) and the true positive rate (y-axis) are plotted in a vector graph.
S13、当所述血管内皮功能异常指数大于异常指数阈值时,确定所述目标用户存在血管内皮功能障碍。S13: When the vascular endothelial dysfunction index is greater than the abnormal index threshold, it is determined that the target user has vascular endothelial dysfunction.
具体的,针对不同的目标用户人群,确定不同的目标用户人群对应的异常指数阈值,从而根据不同的目标用户人群对应的异常指数阈值,确定目标用户是否存在血管内皮功能障碍。Specifically, for different target user groups, the abnormal index thresholds corresponding to the different target user groups are determined, so as to determine whether the target users have endothelial dysfunction according to the abnormal index thresholds corresponding to the different target user groups.
示例性的,当目标人群没有明确分类时,根据公式计算该患者的异常指数阈值,若异常指数阈值EDscore>-0.38,则提示内皮功能障碍。当目标用户为高血压患者时,根据公式计算该患者的异常指数阈值,若异常指数阈值EDscore>-0.282,则提示内皮功能障碍。For example, when the target population is not clearly classified, the abnormal index threshold of the patient is calculated according to the formula, and if the abnormal index threshold EDscore>-0.38, it indicates endothelial dysfunction. When the target user is a hypertensive patient, the abnormal index threshold of the patient is calculated according to the formula, and if the abnormal index threshold EDscore>-0.282, it indicates endothelial dysfunction.
本公开提供的微血管内皮功能检测方法,获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值,根据基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值,确定血管内皮功能异常指数,当血管内皮功能异常指数大于异常指数阈值时,确定目标用户存在血管内皮功能障碍。可见,本公开实施例可以在获取到目标用户的检查信息,即获取到基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值后,通过检测信息自动确定目标用户是否存在血管内皮功能障碍,提高了检测效率,同时,由于整个流程的步骤均是由计算机执行的,不用使用昂贵的EndoPAT仪器,所以可以降低检测成本。The microvascular endothelial function detection method provided by the present disclosure obtains the target user's basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value, determines the abnormal endothelial function index according to the basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value, and determines that the target user has endothelial dysfunction when the abnormal endothelial function index is greater than the abnormal index threshold. It can be seen that the embodiment of the present disclosure can automatically determine whether the target user has endothelial dysfunction through the detection information after obtaining the target user's inspection information, that is, obtaining the basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value, thereby improving the detection efficiency. At the same time, since the steps of the entire process are all executed by a computer, there is no need to use expensive EndoPAT instruments, so the detection cost can be reduced.
在一个实施例中,如图2所示,提供了一种微血管内皮功能检测装置200,包括:In one embodiment, as shown in FIG2 , a microvascular endothelial function detection device 200 is provided, comprising:
获取模块210,用于获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值;An acquisition module 210 is used to acquire the target user's basic blood oxygen saturation, blood oxygen saturation net recovery time, and blood perfusion index increase value;
计算模块220,用于根据所述基础血氧饱和度、所述血氧饱和度净恢复时间、所述血流灌注指数增加值,确定血管内皮功能异常指数;A calculation module 220, configured to determine a vascular endothelial dysfunction index according to the basal blood oxygen saturation, the blood oxygen saturation net recovery time, and the blood perfusion index increase value;
确定模块230,用于当所述血管内皮功能异常指数大于异常指数阈值时,确定所述目标用户存在血管内皮功能障碍。The determination module 230 is used to determine that the target user has endothelial dysfunction when the endothelial dysfunction index is greater than an abnormality index threshold.
作为本公开实施例一种可选的实施方式,所述获取模块,具体用于:As an optional implementation of the embodiment of the present disclosure, the acquisition module is specifically used to:
记录所述目标用户的血氧饱和度由第一血氧饱和度恢复到第二血氧饱和度的时间为第一时长;所述第一血氧饱和度用于表示所述目标用户在肱动脉血流阻断预设时长时的血氧饱和度,所述第二血氧饱和度基于所述基础血氧饱和度乘以预设系数得到;The time for the target user's blood oxygen saturation to recover from the first blood oxygen saturation to the second blood oxygen saturation is recorded as a first duration; the first blood oxygen saturation is used to represent the blood oxygen saturation of the target user when the brachial artery blood flow is blocked for a preset duration, and the second blood oxygen saturation is obtained based on the basic blood oxygen saturation multiplied by a preset coefficient;
记录从所述目标用户的肱动脉血流被阻断时到恢复脉搏的时间为第二时长;Recording the time from when the brachial artery blood flow of the target user is blocked to when the pulse is restored as the second duration;
将所述第一时长与所述第二时长进行做差运算,获取所述血氧饱和度净恢复时间。A difference operation is performed between the first time length and the second time length to obtain the blood oxygen saturation net recovery time.
作为本公开实施例一种可选的实施方式,所述获取模块,具体用于:As an optional implementation of the embodiment of the present disclosure, the acquisition module is specifically used to:
获取所述目标用户的基础血流灌注指数和第一血流灌注指数;所述第一血流灌注指数为所述目标用户的肱动脉血流被阻断到恢复脉搏的过程中最大的血流灌注指数;Acquire a basic blood perfusion index and a first blood perfusion index of the target user; the first blood perfusion index is the maximum blood perfusion index of the target user during the process from when the brachial artery blood flow is blocked to when the pulse is restored;
根据所述第一血流灌注指数和所述基础血流灌注指数,确定所述血流灌注指数增加值。The blood perfusion index increase value is determined according to the first blood perfusion index and the basic blood perfusion index.
作为本公开实施例一种可选的实施方式,所述装置还包括:As an optional implementation of the embodiment of the present disclosure, the device further includes:
分类模块,用于根据目标用户人群的属性,对所述目标用户人群进行分类;A classification module, used to classify the target user population according to the attributes of the target user population;
阈值确定模块,用于针对不同的目标用户人群,确定不同目标用户人群对应的异常指数阈值。The threshold determination module is used to determine the abnormal index thresholds corresponding to different target user groups.
作为本公开实施例一种可选的实施方式,所述计算模块,具体用于:As an optional implementation of the embodiment of the present disclosure, the computing module is specifically used for:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
作为本公开实施例一种可选的实施方式,当所述目标用户的年龄大于等于第一预设年龄时,所述计算模块,具体用于:As an optional implementation of the embodiment of the present disclosure, when the age of the target user is greater than or equal to a first preset age, the calculation module is specifically configured to:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
作为本公开实施例一种可选的实施方式,当所述目标用户的年龄大于等于第二预设年龄,且小于所述第一预设年龄时,所述计算模块,具体用于:As an optional implementation of the embodiment of the present disclosure, when the age of the target user is greater than or equal to a second preset age and less than the first preset age, the calculation module is specifically configured to:
根据公式,计算血管内皮功能异常指数;According to the formula , calculate the endothelial dysfunction index;
其中,表示血管内皮功能异常指数,表示血氧饱和度净恢复时间,表示基础血氧饱和度,表示血流灌注指数增加值。in, Represents the endothelial dysfunction index. Indicates the net recovery time of blood oxygen saturation, Indicates the basic blood oxygen saturation, Indicates the increase in blood perfusion index.
本公开提供的微血管内皮功能检测装置,获取目标用户的基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值,根据基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值,确定血管内皮功能异常指数,当血管内皮功能异常指数大于异常指数阈值时,确定目标用户存在血管内皮功能障碍。可见,本公开实施例可以在获取到目标用户的检查信息,即获取到基础血氧饱和度、血氧饱和度净恢复时间以及血流灌注指数增加值后,通过检查信息由计算机自动确定目标用户是否存在血管内皮功能障碍,无需采用EndoPAT仪器,提高了检测效率。The microvascular endothelial function detection device provided by the present disclosure obtains the target user's basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value, and determines the abnormal endothelial function index according to the basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value. When the abnormal endothelial function index is greater than the abnormal index threshold, it is determined that the target user has endothelial dysfunction. It can be seen that after obtaining the inspection information of the target user, that is, obtaining the basic blood oxygen saturation, blood oxygen saturation net recovery time and blood perfusion index increase value, the computer can automatically determine whether the target user has endothelial dysfunction through the inspection information, without using the EndoPAT instrument, thereby improving the detection efficiency.
关于微血管内皮功能检测装置的具体限定可以参见上文中对于微血管内皮功能检测方法的限定,在此不再赘述。上述微血管内皮功能检测装置中的各个模块可全部或部分通过软件、硬件及其组合来实现。上述各模块可以硬件形式内嵌于或独立于电子设备的处理器中,也可以软件形式存储于电子设备的处理器中,以便于处理器调用执行以上各个模块对应的操作。The specific definition of the microvascular endothelial function detection device can be found in the definition of the microvascular endothelial function detection method above, which will not be repeated here. Each module in the above-mentioned microvascular endothelial function detection device can be implemented in whole or in part by software, hardware and a combination thereof. The above-mentioned modules can be embedded in or independent of the processor of the electronic device in the form of hardware, or can be stored in the processor of the electronic device in the form of software, so that the processor can call and execute the operations corresponding to the above modules.
本公开实施例还提供了一种电子设备,图3为本公开实施例提供的电子设备的结构示意图。如图3所示,本实施例提供的电子设备包括:存储器31和处理器32,存储器31用于存储计算机程序;处理器32用于调用计算机程序时执行上述方法实施例提供的微血管内皮功能检测方法中任一实施例所执行的步骤。所述电子设备包括通过系统总线连接的处理器、存储器、通信接口、显示屏和输入装置。其中,所述电子设备的处理器用于提供计算和控制能力。所述电子设备的存储器包括非易失性存储介质、内存储器。所述非易失性存储介质存储有操作系统和计算机程序。所述内存储器为非易失性存储介质中的操作系统和计算机程序的运行提供环境。所述计算机程序被处理器执行时以实现一种微血管内皮功能检测方法。所述电子设备的显示屏可以是液晶显示屏或者电子墨水显示屏,所述电子设备的输入装置可以是显示屏上覆盖的触摸层,也可以是计算机设备外壳上设置的按键、轨迹球或触控板,还可以是外接的键盘、触控板或鼠标等。The embodiment of the present disclosure also provides an electronic device, and FIG3 is a schematic diagram of the structure of the electronic device provided by the embodiment of the present disclosure. As shown in FIG3, the electronic device provided by the present embodiment includes: a memory 31 and a processor 32, the memory 31 is used to store a computer program; the processor 32 is used to execute the steps performed by any embodiment of the microvascular endothelial function detection method provided by the above method embodiment when calling the computer program. The electronic device includes a processor, a memory, a communication interface, a display screen and an input device connected through a system bus. Among them, the processor of the electronic device is used to provide computing and control capabilities. The memory of the electronic device includes a non-volatile storage medium and an internal memory. The non-volatile storage medium stores an operating system and a computer program. The internal memory provides an environment for the operation of the operating system and the computer program in the non-volatile storage medium. When the computer program is executed by the processor, a microvascular endothelial function detection method is implemented. The display screen of the electronic device can be a liquid crystal display screen or an electronic ink display screen, and the input device of the electronic device can be a touch layer covered on the display screen, or a key, trackball or touchpad set on the housing of the computer device, or an external keyboard, touchpad or mouse.
本领域技术人员可以理解,图3中示出的结构,仅仅是与本公开方案相关的部分结构的框图,并不构成对本公开方案所应用于其上的计算机设备的限定,具体的电子设备可以包括比图中所示更多或更少的部件,或者组合某些部件,或者具有不同的部件布置。Those skilled in the art will understand that the structure shown in FIG. 3 is merely a block diagram of a partial structure related to the scheme of the present disclosure, and does not constitute a limitation on the computer device to which the scheme of the present disclosure is applied. The specific electronic device may include more or fewer components than shown in the figure, or combine certain components, or have a different arrangement of components.
在一个实施例中,本公开提供的电池漏液监测系统可以实现为一种计算机的形式,计算机程序可以在如图3所示的电子设备上运行。电子设备的存储器中可存储组成该电子设备的微血管内皮功能检测装置的各个程序模块,比如,图2中所示的获取模块210、计算模块220和确定模块230。各个程序模块构成的计算机程序使得处理器执行本说明书描述的本公开各个实施例的电子设备的微血管内皮功能检测方法中的步骤。In one embodiment, the battery leakage monitoring system provided by the present disclosure can be implemented in the form of a computer, and the computer program can be run on the electronic device shown in Figure 3. The memory of the electronic device can store various program modules constituting the microvascular endothelial function detection device of the electronic device, such as the acquisition module 210, the calculation module 220 and the determination module 230 shown in Figure 2. The computer program composed of various program modules enables the processor to execute the steps of the microvascular endothelial function detection method of the electronic device of each embodiment of the present disclosure described in this specification.
本公开实施例还提供一种计算机可读存储介质,该计算机可读存储介质上存储有计算机程序,计算机程序被处理器执行时实现上述方法实施例提供的微血管内皮功能检测方法。The embodiment of the present disclosure further provides a computer-readable storage medium having a computer program stored thereon. When the computer program is executed by a processor, the microvascular endothelial function detection method provided by the above method embodiment is implemented.
本领域技术人员应明白,本公开的实施例可提供为方法、系统、或计算机程序产品。因此,本公开可采用完全硬件实施例、完全软件实施例、或结合软件和硬件方面的实施例的形式。而且,本公开可采用在一个或多个其中包含有计算机可用程序代码的计算机可用存储介质上实施的计算机程序产品的形式。Those skilled in the art will appreciate that the embodiments of the present disclosure may be provided as methods, systems, or computer program products. Therefore, the present disclosure may take the form of a complete hardware embodiment, a complete software embodiment, or an embodiment combining software and hardware. Furthermore, the present disclosure may take the form of a computer program product implemented on one or more computer-usable storage media containing computer-usable program code.
处理器可以是中央判断单元(CentralProcessingUnit,CPU),还可以是其他通用处理器、数字信号处理器(DigitalSignalProcessor,DSP)、专用集成电路(ApplicationSpecific Integrated Circuit,ASIC)、现成可编程门阵列(Field-Programmable GateArray,FPGA)或者其他可编程逻辑器件、分立门或者晶体管逻辑器件、分立硬件组件等。通用处理器可以是微处理器或者该处理器也可以是任何常规的处理器等。The processor may be a central processing unit (CPU), or other general-purpose processors, digital signal processors (DSP), application-specific integrated circuits (ASIC), field-programmable gate arrays (FPGA) or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc. A general-purpose processor may be a microprocessor or any conventional processor, etc.
存储器可能包括计算机可读介质中的非永久性存储器,随机存取存储器(RAM)和/或非易失性内存等形式,如只读存储器(ROM)或闪存(flashRAM)。存储器是计算机可读介质的示例。The memory may include non-permanent memory in a computer-readable medium, random access memory (RAM) and/or non-volatile memory in the form of read-only memory (ROM) or flash RAM. The memory is an example of a computer-readable medium.
计算机可读介质包括永久性和非永久性、可移动和非可移动存储介质。存储介质可以由任何方法或技术来实现信息存储,信息可以是计算机可读指令、数据结构、程序的模块或其他数据。计算机的存储介质的例子包括,但不限于相变内存(PRAM)、静态随机存取存储器(SRAM)、动态随机存取存储器(DRAM)、其他类型的随机存取存储器(RAM)、只读存储器(ROM)、电可擦除可编程只读存储器(EEPROM)、快闪记忆体或其他内存技术、只读光盘只读存储器(CD-ROM)、数字多功能光盘(DVD)或其他光学存储、磁盒式磁带,磁盘存储或其他磁性存储设备或任何其他非传输介质,可用于存储可以被计算设备访问的信息。根据本文中的界定,计算机可读介质不包括暂存电脑可读媒体(transitorymedia),如调制的数据信号和载波。Computer readable media include permanent and non-permanent, removable and non-removable storage media. Storage media can be implemented by any method or technology to store information, and the information can be computer-readable instructions, data structures, program modules or other data. Examples of computer storage media include, but are not limited to, phase change memory (PRAM), static random access memory (SRAM), dynamic random access memory (DRAM), other types of random access memory (RAM), read-only memory (ROM), electrically erasable programmable read-only memory (EEPROM), flash memory or other memory technology, compact disk read-only memory (CD-ROM), digital versatile disk (DVD) or other optical storage, magnetic cassettes, magnetic disk storage or other magnetic storage devices or any other non-transmission media that can be used to store information that can be accessed by a computing device. As defined herein, computer readable media does not include temporary computer readable media (transitory media), such as modulated data signals and carrier waves.
需要说明的是,在本文中,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。在没有更多限制的情况下,由语句“包括一个……”限定的要素,并不排除在包括所述要素的过程、方法、物品或者设备中还存在另外的相同要素。It should be noted that, in this article, the terms "include", "comprises" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, an element defined by the sentence "comprises a ..." does not exclude the existence of other identical elements in the process, method, article or device including the element.
以上所述仅是本公开的具体实施方式,使本领域技术人员能够理解或实现本公开。对这些实施例的多种修改对本领域的技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本公开的精神或范围的情况下,在其它实施例中实现。因此,本公开将不会被限制于本文所述的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。The above description is only a specific embodiment of the present disclosure, so that those skilled in the art can understand or implement the present disclosure. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present disclosure. Therefore, the present disclosure will not be limited to the embodiments described herein, but will conform to the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202411290938.1A CN118830816B (en) | 2024-09-14 | 2024-09-14 | Microvascular endothelial function detection method, device, electronic equipment and storage medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202411290938.1A CN118830816B (en) | 2024-09-14 | 2024-09-14 | Microvascular endothelial function detection method, device, electronic equipment and storage medium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN118830816A true CN118830816A (en) | 2024-10-25 |
| CN118830816B CN118830816B (en) | 2024-12-17 |
Family
ID=93142852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202411290938.1A Active CN118830816B (en) | 2024-09-14 | 2024-09-14 | Microvascular endothelial function detection method, device, electronic equipment and storage medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118830816B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070225606A1 (en) * | 2006-03-22 | 2007-09-27 | Endothelix, Inc. | Method and apparatus for comprehensive assessment of vascular health |
| CN103536281A (en) * | 2013-10-30 | 2014-01-29 | 广东省医疗器械研究所 | Vascular endothelial function detecting device based on fingertip temperature change |
| CN104027097A (en) * | 2014-06-06 | 2014-09-10 | 首都医科大学 | Vascular function noninvasive detecting method and device |
| CN105852910A (en) * | 2016-04-18 | 2016-08-17 | 何宗彦 | Equipment and method for detecting vascular endothelial functions by Doppler ultrasonography |
| CN106132309A (en) * | 2014-03-25 | 2016-11-16 | 恩多德里克斯有限公司 | For the method and apparatus assessing vascular health |
| WO2021006768A1 (en) * | 2019-07-11 | 2021-01-14 | Акционерное общество "Елатомский приборный завод" | Method and device for evaluating skin microcirculatory dysfunction |
-
2024
- 2024-09-14 CN CN202411290938.1A patent/CN118830816B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070225606A1 (en) * | 2006-03-22 | 2007-09-27 | Endothelix, Inc. | Method and apparatus for comprehensive assessment of vascular health |
| CN103536281A (en) * | 2013-10-30 | 2014-01-29 | 广东省医疗器械研究所 | Vascular endothelial function detecting device based on fingertip temperature change |
| CN106132309A (en) * | 2014-03-25 | 2016-11-16 | 恩多德里克斯有限公司 | For the method and apparatus assessing vascular health |
| CN104027097A (en) * | 2014-06-06 | 2014-09-10 | 首都医科大学 | Vascular function noninvasive detecting method and device |
| CN105852910A (en) * | 2016-04-18 | 2016-08-17 | 何宗彦 | Equipment and method for detecting vascular endothelial functions by Doppler ultrasonography |
| WO2021006768A1 (en) * | 2019-07-11 | 2021-01-14 | Акционерное общество "Елатомский приборный завод" | Method and device for evaluating skin microcirculatory dysfunction |
Also Published As
| Publication number | Publication date |
|---|---|
| CN118830816B (en) | 2024-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Song et al. | Value of the combination of renal resistance index and central venous pressure in the early prediction of sepsis-induced acute kidney injury | |
| US8352006B1 (en) | Diagnosing hypoxia by monitoring changes in oxygen saturation | |
| Lívia Goldraich et al. | Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure | |
| Foo et al. | Pulse transit time as an indirect marker for variations in cardiovascular related reactivity | |
| Stephan et al. | Clinical evaluation of circulating blood volume in critically ill patients—contribution of a clinical scoring system | |
| US9044147B2 (en) | Detection of noise during heart beat variation evaluation | |
| JP2012517286A (en) | Detection of vascular symptoms using arterial pressure waveform data | |
| Yan et al. | Combination of B-type natriuretic peptide and minute ventilation/carbon dioxide production slope improves risk stratification in patients with diastolic heart failure | |
| US8306611B2 (en) | Method and system for use in monitoring left ventricular dysfunction | |
| Yildiran et al. | Low pulse pressure as a predictor of death in patients with mild to advanced heart failure | |
| JP2019201886A (en) | Atrial fibrillation detection device, atrial fibrillation detection method, and computer program | |
| Banjade et al. | Systemic venous congestion reviewed | |
| Koroboki et al. | The impact of nocturnal hypertension and nondipping status on left ventricular mass: a cohort study | |
| Suliman et al. | Echocardiographic predictors of outcome in acute heart failure patients in sub-Saharan Africa: insights from THESUS-HF | |
| CN118830816A (en) | Microvascular endothelial function detection method, device, electronic equipment and storage medium | |
| CN116564531A (en) | A construction method of DPN feature screening model based on machine learning algorithm | |
| Yasar et al. | Left ventricular myocardial performance index in prehypertensive patients with normal coronary arteries | |
| Bardakcı et al. | Prediction of adverse outcomes using non-endoscopic scoring systems in patients over 80 years of age who present with the upper gastrointestinal bleeding in the emergency department | |
| Cui et al. | Evaluating the Role of Critical Care Ultrasonography in Predicting Volume Responsiveness Among Septic Shock Patients Undergoing Fluid Resuscitation: A Clinical Study | |
| Hou et al. | Evaluation of radial artery pulse pressure effects on detection of stroke volume changes after volume loading maneuvers in cardiac surgical patients | |
| Trevethan | Toe systolic pressures and toe-brachial indices: uses, abuses, and shades of gray | |
| Cao et al. | A comprehensive nomogram integrating phonocardiogram and echocardiogram features for the diagnosis of heart failure with preserved ejection fraction | |
| Tezuka et al. | Feasibility of Portable Laser Doppler Flowmeter for Foot Blood Flow Assessment in Patients With Chronic Limb Threatening Ischaemia | |
| US20230270343A1 (en) | Techniques for screening and monitoring patients for aortic aneurysms | |
| Ng et al. | Evaluation for occult sepsis incorporating NIRS and emergency sonography |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |